newsfilter
← Latest News
GlobeNewswire·

Translate Bio Achieves Manufacturing Milestone Related to Influenza mRNA Vaccine Program

-- $50 million milestone payment to be received this month for successful manufacturing, release, and delivery of clinical drug product to support influenza mRNA vaccine clinical trial anticipated to begin in the coming weeks -- LEXINGTON, Mass.,